Back to News
Market Impact: 0.15
TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer
Source: PRWeb
Management & GovernanceHealthcare & Biotech
TETRAPHARM appointed Rolf Sass Sørensen as chief executive, succeeding co-founder Martin Rose. Rose and co-founder Jesper Breum are moving on to pursue new biotech ventures while remaining shareholders in TETRAPHARM; the article provides no further details on the appointment or company outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss
- Trump created a committee to dig into the Fed's Lisa Cook. What is it and what comes next?
- ‘Indentured servants’: US green card move will hit thousands of IT workers
- Teva wins FDA approval for monthly schizophrenia injection Weltruza
- BofA downgrades Alignment Healthcare stock rating on star rating drop
- Trump launches probe into Federal Reserve Governor Lisa Cook